TATYANA KORABLEVA: Open Payments
NPI 1912272113 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,673 in 85 payments from 18 companies in 2025. Trend: 2023 $2,062 · 2024 $1,653 · 2025 $1,673
Food & beverage: $1,673
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $359 |
| Janssen Biotech, Inc. | 15 | $295 |
| UCB, Inc. | 15 | $263 |
| Mallinckrodt Hospital Products Inc. | 6 | $136 |
| ABBVIE INC. | 6 | $131 |
| Radius Health, Inc. | 5 | $97 |
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Lilly USA, LLC | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
Products named: TREMFYA, Bimzelx, OTEZLA, ACTHAR, Tymlos, SKYRIZI, RINVOQ, SAPHNELO.
Industry payments across FL — which companies pay providers there.
